Cargando…

Competing Risks Model for Prediction of Small for Gestational Age Neonates and the Role of Second Trimester Soluble Fms-like Tyrosine Kinase-1

Small for gestational age (SGA) fetuses/neonates are characterized by the increased risk for adverse outcomes that can be reduced if the condition is identified antenatally. We have recently developed a new approach in SGA prediction that considers SGA a spectrum condition that is reflected in two d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowacka, Urszula, Papastefanou, Ioannis, Bouariu, Alexandra, Syngelaki, Argyro, Nicolaides, Kypros H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432206/ https://www.ncbi.nlm.nih.gov/pubmed/34501234 http://dx.doi.org/10.3390/jcm10173786

Ejemplares similares

First-Trimester Screening for Gestational Diabetes Mellitus in Twin Pregnancies
por: Buerger, Olga, et al.
Publicado: (2021)

First Trimester Prediction of Adverse Pregnancy Outcomes—Identifying Pregnancies at Risk from as Early as 11–13 Weeks
por: Bouariu, Alexandra, et al.
Publicado: (2022)

Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
por: Weiner, Carl P., et al.
Publicado: (2022)

Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down’s syndrome, preterm delivery and preeclampsia
por: Chambers, Anne E, et al.
Publicado: (2012)

Maternal Plasma RNA in First Trimester Nullipara for the Prediction of Spontaneous Preterm Birth ≤ 32 Weeks: Validation Study
por: Weiner, Carl P., et al.
Publicado: (2023)

Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review
por: Jacobs, Marni, et al.
Publicado: (2011)

Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy
por: Selvarajan, Sathya, et al.
Publicado: (2019)

Second-trimester urine nephrin:creatinine ratio versus soluble fms-like tyrosine kinase-1:placental growth factor ratio for prediction of preeclampsia among asymptomatic women
por: Zhai, Tianyue, et al.
Publicado: (2016)

Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD
por: Zsengellér, Zsuzsanna K., et al.
Publicado: (2019)

First-Trimester Circulating 25-Hydroxyvitamin D Levels and Development of Gestational Diabetes Mellitus
por: Makgoba, Mahlatse, et al.
Publicado: (2011)

Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder
por: Lumbanraja, Sarma, et al.
Publicado: (2022)

The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
por: Schulz, Annika, et al.
Publicado: (2023)

Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review
por: Kosinska-Kaczynska, Katarzyna, et al.
Publicado: (2020)

Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy–associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1–placental growth factor ratio in the early second trimester
por: Huang, Tianhua, et al.
Publicado: (2023)

First-Trimester Prediction of Gestational Diabetes Mellitus: Examining the Potential of Combining Maternal Characteristics and Laboratory Measures
por: Savvidou, Makrina, et al.
Publicado: (2010)

Maternal Race and Stillbirth: Cohort Study and Systematic Review with Meta-Analysis
por: Arechvo, Anastasija, et al.
Publicado: (2022)

Preeclampsia Prevention by Timed Birth at Term
por: Magee, Laura A., et al.
Publicado: (2023)

Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
por: Sánchez-Aranguren, Lissette C., et al.
Publicado: (2018)

Soluble Fms-Like Tyrosine Kinase-1 Is A Marker of Endothelial Dysfunction During Sepsis
por: Greco, Marilena, et al.
Publicado: (2018)

Early Detection of Preeclampsia Using Circulating Small non-coding RNA
por: Yoffe, Liron, et al.
Publicado: (2018)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
por: Rădulescu, Carmen, et al.
Publicado: (2016)

Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis
por: Dumnicka, Paulina, et al.
Publicado: (2016)

How Soluble Fms-Like Tyrosine Kinase 1 Could Contribute to Blood-Brain Barrier Dysfunction in Preeclampsia?
por: Torres-Vergara, Pablo, et al.
Publicado: (2022)

Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
por: Dupont, Vincent, et al.
Publicado: (2022)

Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study
por: Kahn, Susan R, et al.
Publicado: (2011)

An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy
por: Dixon, Peter H., et al.
Publicado: (2017)

Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II
por: Murphy, Sydney R, et al.
Publicado: (2015)

The Soluble Fms-like Tyrosine Kinase-1 Contributes to Structural and Functional Changes in Endothelial Cells in Chronic Kidney Disease
por: Schulz, Annika, et al.
Publicado: (2022)

Impact of Second Trimester Maternal Dietary Intake on Gestational Weight Gain and Neonatal Birth Weight
por: Pathirathna, Malshani L., et al.
Publicado: (2017)

A Case-Control Study of Maternal Periconceptual and Pregnancy Recreational Drug Use and Fetal Malformation Using Hair Analysis
por: David, Anna L., et al.
Publicado: (2014)

Expanded conventional first trimester screening
por: Carmichael, Jonathan B., et al.
Publicado: (2017)

Small‐for‐gestational‐age fetus diagnosed in the second trimester: Possible etiologies and short‐term neonatal outcomes
por: Pasquini, Lucia, et al.
Publicado: (2023)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
por: Hannan, Natalie J., et al.
Publicado: (2017)

Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of concept
por: Winger, Edward E., et al.
Publicado: (2018)

Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks’ gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study
por: MacDonald, Teresa M., et al.
Publicado: (2018)

Soluble fms-like tyrosine kinase 1, placental growth factor and procalcitonin as biomarkers of gram-negative sepsis: Analysis through a derivation and a validation cohort
por: Vittoros, Vasileios, et al.
Publicado: (2021)

Association between serum soluble fms-like tyrosine kinase-1 and the central choroidal thickness during pregnancy: a prospective study
por: Suzuki, Takafumi, et al.
Publicado: (2021)

Circulating soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor during pregnancy in normotensive women in KwaZulu-Natal, South Africa
por: Ogunlola, Muhammed, et al.
Publicado: (2019)

Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study
por: Levine, Richard J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bfs7ssrel1pvlpf624ug67n8ju